SALK NEWS

Salk Institute for Biological Studies - SALK NEWS

Salk News


The battle for CRTC2: how obesity increases the risk for diabetes

La Jolla, CA—Obesity is probably the most important factor in the development of insulin resistance, but science’s understanding of the chain of events is still spotty. Now, researchers at the Salk Institute for Biological Studies have filled in the gap and identified the missing link between the two. Their findings, to be published in the June 21, 2009 advance online edition of the journal Nature, explain how obesity sets the stage for diabetes and why thin people can become insulin-resistant.


Hungry cells: Tumor metabolism discovery opens new detection and treatment possibilities for rare form of colon cancer

LA JOLLA, CA-People who suffer from Peutz-Jeghers syndrome, a rare inherited cancer syndrome, develop gastrointestinal polyps and are predisposed to colon cancer and other tumor types. Carefully tracing the cellular chain-of-command that links nutrient intake to cell growth (and which is interrupted in Peutz-Jeghers syndrome), allowed researchers at the Salk Institute for Biological Studies to exploit the tumors' weak spot.


Genetic Re-disposition: Combined stem cell-gene therapy approach cures human genetic disease in vitro

La Jolla, CA—A study led by researchers at the Salk Institute for Biological Studies, has catapulted the field of regenerative medicine significantly forward, proving in principle that a human genetic disease can be cured using a combination of gene therapy and induced pluripotent stem (iPS) cell technology. The study, published in the May 31, 2009 early online edition of Nature, is a major milestone on the path from the laboratory to the clinic.


Salk Scientist Inder Verma to Receive 2009 Outstanding Achievement Award from American Society of Gene Therapy

La Jolla, CA—Salk Professor Inder M. Verma, Ph.D., one of the world’s leading authorities on the development and use of engineered viruses for gene therapy, has been named the 2009 recipient of the American Society of Gene Therapy’s Outstanding Achievement Award. The award recognizes an ASGT member who has conducted groundbreaking research or achieved a lifetime of significant scientific contributions to the field of gene therapy. Verma is only the second scientist honored with the society’s Outstanding Achievement Award, which debuted in 2008.


Salk Institute Scientist Plays Pivotal Role in More Than $100 Mill National “Stand Up To Cancer” Fundraising, Pancreatic Cancer Research “Dream Team”

La Jolla-More than three years ago, while serving as president-elect and then president of the American Association for Cancer Research (AACR), Salk scientist Geoff Wahl had an epiphany: cancer research needed a grassroots American fundraising movement reminiscent of the polio-inspired March of Dimes.


Good fences make good neighbors:

La Jolla, CA-Our genome is a patchwork of neighborhoods that couldn’t be more different: Some areas are hustling and bustling with gene activity, while others are sparsely populated and in perpetual lock-down. Breaking down just a few of the molecular fences that separate them blurs the lines and leads to the inactivation of at least two tumor suppressor genes, according to researchers at the Salk Institute for Biological Studies.


Salk Scientist wins the 2009 McKnight Scholar Award

La Jolla, CA—Dr. Tatyana Sharpee, an assistant professor in the Laboratory for Computational Biology, has been named a 2009 McKnight Scholar. She will receive a grant of $225,000 over a three-year period to study “Discrete representation of visual shapes in the brain.”


Salk Receives $6.6 Million Grant to Develop Stem Cell-Based Treatments for Incurable Diseases

La Jolla, CA — The Salk Institute for Biological Studies has been awarded a $6.6 million grant – the largest single award in the latest competition — by the California Institute Regenerative Medicine (CIRM) for research aimed at translating basic science into clinical cures. The funds are part of $67.7 million Early Translational Grants CIRM provided to 15 research organizations on Wednesday.


Salk scientist Marc Montminy elected to National Academy of Sciences

La Jolla, CA – Salk researcher Marc R. Montminy, M.D., Ph.D., a professor in the Clayton Foundation Laboratories for Peptide Biology, has been elected a member of the National Academy of Sciences, the nation’s most prestigious honorary society for scientists. The Academy made the announcement today during its 146th annual meeting in Washington, DC.


Salk Launches Center for Nutritional Genomics with $5.5 Million Grant from Helmsley Trust

La Jolla, CA — The Salk Institute has received a $5.5 million grant from the Leona M. and Harry B. Helmsley Charitable Trust to launch the Salk Center for Nutritional Genomics. The new Center will employ a molecular approach to nutrition and its impact on the role of metabolism on the immune system, cancer, diabetes and lifespan, thereby increasing the understanding of how nutrients affect health.


Repairing a ‘bad’ reputation?

La Jolla, CA—New research at the Salk Institute for Biological Studies casts the role of a neuronal growth factor receptor—long suspected to facilitate the toxic effects of beta amyloid in Alzheimer’s disease—in a new light, suggesting the molecule actually protects the neuron in the periphery from beta amyloid-induced damage.


How the retina works: Like a multi-layered jigsaw puzzle of receptive fields

La Jolla, CA—About 1.25 million neurons in the retina — each of which views the world only through a small jagged window called a receptive field — collectively form the seamless picture we rely on to navigate our environment. Receptive fields fit together like pieces of a puzzle, preventing “blind spots” and excessive overlap that could blur our perception of the world, according to researchers at the Salk Institute for Biological Studies.


Salk scientist — one of 50 nationwide — selected as HHMI Early Career Scientist

La Jolla, CA—Salk Institute scientist Reuben J. Shaw, Ph.D., has been selected a Howard Hughes Medical Institute Early Career Scientist, the HHMI announced today.


Salk Institute Signs Strategic Alliance with sanofi-aventis

La Jolla, CA—The Salk Institute today announced that it has signed a strategic alliance agreement with sanofi-aventis, establishing a joint program that supports cutting-edge research and promotes an exchange of discoveries focused on scientific advances and therapeutic applications.


Visual attention: how the brain makes the most of the visible world

La Jolla, CA—The visual system has limited capacity and cannot process everything that falls onto the retina. Instead, the brain relies on attention to bring salient details into focus and filter out background clutter. Two recent studies by researchers at the Salk Institute for Biological Studies, one study employing computational modeling techniques and the other experimental techniques, have helped to unravel the mechanisms underlying attention.


Forget it! A biochemical pathway for blocking your worst fears?

La Jolla, CA — A receptor for glutamate, the most prominent neurotransmitter in the brain, plays a key role in the process of “unlearning,” report researchers at the Salk Institute for Biological Studies. Their findings, published in the current issue of the Journal of Neuroscience, could eventually help scientists develop new drug therapies to treat a variety of disorders, including phobias and anxiety disorders, particularly post-traumatic stress disorder.


Stem Cells Yield New Clues to Glut of Glial Cells in Down’s Syndrome, Glioblastoma, and Alzheimer’s Disease

La Jolla, CA—A newly identified molecular pathway that directs stem cells to produce glial cells yields insights into the neurobiology of Down's syndrome and a number of central nervous system disorders characterized by too many glial cells, according to a recent study by researchers at the Salk Institute for Biological Studies.


Salk scientists detect molecular obesity link to insulin resistance, type II diabetes

La Jolla, CA—A molecular switch found in the fat tissue of obese mice is a critical factor in the development of insulin resistance, report scientists at the Salk Institute for Biological Studies. Previously found to increase glucose production by the liver during fasting, the culprit—a protein known as CREB—is also activated in fat tissue of obese mice where it promotes insulin resistance.


Light or fight? Scientists discover how plants make tough survival choices

La Jolla, CA — Ever since insects developed a taste for vegetation, plants have faced the same dilemma: use limited resources to out-compete their neighbors for light to grow, or, invest directly in defense against hungry insects. Now, an international team of scientists at the Salk Institute for Biological Studies and the Institute of Investigaciones Fisiológicas y Ecológicas Vinculadas a la Agronomía (IFEVA) has discovered how plants weigh the tradeoffs and redirect their energies accordingly.


Inder Verma Named First Incumbent of the Irwin Mark Jacobs Chair in Exemplary Life Sciences

La Jolla, CA — The Salk Institute today named principal investigator Inder M. Verma the first incumbent of the Irwin Mark Jacobs Chair in Exemplary Life Sciences. Established to honor its namesake’s exceptional leadership in business and philanthropy, the honor is given to an internationally renowned senior Salk scientist who has made extraordinary discoveries in basic biomedical research and has contributed to the direction and vitality of the Institute.